Aman Singh is a distinguished Rheumatology Executive Sales Specialist at Novartis, where he has made significant strides in the pharmaceutical industry, particularly in the realm of biologics. With a robust background that includes multiple regional and national awards, Aman’s expertise is underscored by his experience...
Aman Singh is a distinguished Rheumatology Executive Sales Specialist at Novartis, where he has made significant strides in the pharmaceutical industry, particularly in the realm of biologics. With a robust background that includes multiple regional and national awards, Aman’s expertise is underscored by his experience at prestigious academic institutions like Stanford and UCSF. His deep understanding of complex reimbursement protocols, including buy & bill and specialty pharmacy processes, positions him as a key resource for healthcare providers navigating the intricacies of treatment access for patients with rheumatological conditions.
Currently, Aman is at the forefront of launching Cosentyx (Secukinumab), a groundbreaking first-in-class biologic specifically designed for patients suffering from Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS). His role not only involves driving sales operations but also educating healthcare professionals about the unique benefits of Cosentyx, which has revolutionized treatment paradigms in rheumatology. Aman’s proficiency in product launch strategies and his comprehensive knowledge of managed care dynamics enable him to effectively communicate the value proposition of Cosentyx to both clinicians and patients.
In addition to his focus on rheumatology, Aman’s diverse skill set encompasses areas such as diabetes, endocrinology, allergy, and immunology, allowing him to approach challenges with a holistic perspective. His commitment to improving patient outcomes through innovative therapies and his ability to foster strong relationships within hospitals and managed care settings make him a pivotal player in advancing Novartis' mission to transform the lives of patients. As he continues to lead initiatives in the rheumatology space, Aman remains dedicated to leveraging his expertise to drive impactful change in the healthcare landscape.
